{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:17:35Z","timestamp":1787026655167,"version":"build-2736575974"},"reference-count":145,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T00:00:00Z","timestamp":1670976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>\n                    Persistent respiratory bacterial infections are a clinical burden in several chronic inflammatory airway diseases and are often associated with neutrophil infiltration into the lungs. Following recruitment, dysregulated neutrophil effector functions such as increased granule release and formation of neutrophil extracellular traps (NETs) result in damage to airway tissue, contributing to the progression of lung disease. Bacterial pathogens are a major driver of airway neutrophilic inflammation, but traditional management of infections with antibiotic therapy is becoming less effective as rates of antimicrobial resistance rise. Bacteriophages (phages) are now frequently identified as antimicrobial alternatives for antimicrobial resistant (AMR) airway infections. Despite growing recognition of their bactericidal function, less is known about how phages influence activity of neutrophils recruited to sites of bacterial infection in the lungs. In this review, we summarize current\n                    <jats:italic>in vitro<\/jats:italic>\n                    and\n                    <jats:italic>in vivo<\/jats:italic>\n                    findings on the effects of phage therapy on neutrophils and their inflammatory mediators, as well as mechanisms of phage-neutrophil interactions. Understanding these effects provides further validation of their safe use in humans, but also identifies phages as a targeted neutrophil-modulating therapeutic for inflammatory airway conditions.\n                  <\/jats:p>","DOI":"10.3389\/fmed.2022.1069929","type":"journal-article","created":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T00:53:18Z","timestamp":1670979198000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Bacteriophage: A new therapeutic player to combat neutrophilic inflammation in chronic airway diseases"],"prefix":"10.3389","volume":"9","author":[{"given":"Daniel R.","family":"Laucirica","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Stick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke W.","family":"Garratt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Kicic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,14]]},"reference":[{"key":"B1","author":"Murphy","year":"2021","journal-title":"Mortality in the United States, 2020."},{"key":"B2","year":"2020","journal-title":"The Top 10 Causes of Death."},{"key":"B3","doi-asserted-by":"publisher","first-page":"F1000FacultyRev","DOI":"10.12688\/f1000research.18411.1","article-title":"Understanding the role of neutrophils in chronic inflammatory airway disease.","volume":"8","author":"Jasper","year":"2019","journal-title":"F1000Res."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/srep34338","article-title":"Biodiversity of bacteriophages: morphological and biological properties of a large group of phages isolated from urban sewage.","volume":"6","author":"Jurczak-Kurek","year":"2016","journal-title":"Sci Rep."},{"key":"B5","doi-asserted-by":"publisher","first-page":"226","DOI":"10.4161\/viru.25991","article-title":"A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens.","volume":"5","author":"Wittebole","year":"2014","journal-title":"Virulence."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1093\/femsle\/fnv242","article-title":"Safety and efficacy of phage therapy via the intravenous route.","volume":"363","author":"Speck","year":"2016","journal-title":"FEMS Microbiol Lett."},{"key":"B7","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.virol.2012.09.002","article-title":"Oral T4-like phage cocktail application to healthy adult volunteers from Bangladesh.","volume":"434","author":"Sarker","year":"2012","journal-title":"Virology."},{"key":"B8","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ebiom.2015.12.023","article-title":"Oral phage therapy of acute bacterial diarrhea with two Coliphage preparations: a randomized trial in children from Bangladesh.","volume":"4","author":"Sarker","year":"2016","journal-title":"EBioMedicine."},{"key":"B9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.4161\/bact.1.2.14590","article-title":"Pros and cons of phage therapy.","volume":"1","author":"Loc-Carrillo","year":"2011","journal-title":"Bacteriophage."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00513","article-title":"Advantages and limitations of bacteriophages for the treatment of bacterial infections.","volume":"10","author":"Principi","year":"2019","journal-title":"Front Pharmacol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1128\/AAC.48.7.2558-2569.2004","article-title":"In vitro and in vivo bacteriolytic activities of Escherichia coli phages: implications for phage therapy.","volume":"48","author":"Chibani-Chennoufi","year":"2004","journal-title":"Antimicrob Agents Chemother."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202012435","article-title":"Biological foundations of successful bacteriophage therapy.","volume":"14","author":"Venturini","year":"2022","journal-title":"EMBO Mol Med."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/femsre\/fuab040","article-title":"Recent progress toward the implementation of phage therapy in Western medicine.","volume":"46","author":"Pirnay","year":"2022","journal-title":"FEMS Microbiol Rev."},{"key":"B14","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1093\/femsre\/fuaa017","article-title":"Current challenges and future opportunities of phage therapy.","volume":"44","author":"Pires","year":"2020","journal-title":"FEMS Microbiol Rev."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e208","DOI":"10.1016\/S1473-3099(21)00612-5","article-title":"Safety and efficacy of phage therapy in difficult-to-treat infections: a systematic review.","volume":"22","author":"Uyttebroek","year":"2022","journal-title":"Lancet Infect Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.addr.2018.08.001","article-title":"Phage therapy for respiratory infections.","volume":"133","author":"Chang","year":"2018","journal-title":"Adv Drug Deliv Rev."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.593988","article-title":"Overcoming challenges to make bacteriophage therapy standard clinical treatment practice for cystic fibrosis.","volume":"11","author":"Ng","year":"2020","journal-title":"Front Microbiol."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/v9020036","article-title":"A3R phage and Staphylococcus aureus lysate do not induce neutrophil degranulation.","volume":"9","author":"Borysowski","year":"2017","journal-title":"Viruses."},{"key":"B19","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1089\/vim.2010.0001","article-title":"The effects of T4 and A3\/R phage preparations on whole-blood monocyte and neutrophil respiratory burst.","volume":"23","author":"Borysowski","year":"2010","journal-title":"Viral Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.jcf.2020.11.017","article-title":"Phages as immunomodulators and their promising use as anti-inflammatory agents in a cftr loss-of-function zebrafish model.","volume":"20","author":"Cafora","year":"2021","journal-title":"J Cyst Fibros."},{"key":"B21","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.chom.2017.06.0","article-title":"Synergy between the host immune system and bacteriophage is essential for successful phage therapy against an acute respiratory pathogen.","volume":"22","author":"Roach","year":"2017","journal-title":"Cell Host Microbe."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9123800","article-title":"Impact of Pseudomonas aeruginosa infection on patients with chronic inflammatory airway diseases.","volume":"9","author":"Garcia-Clemente","year":"2020","journal-title":"J Clin Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1164\/rccm.201011-1892OC","article-title":"Infection, inflammation, and lung function decline in infants with cystic fibrosis.","volume":"184","author":"Pillarisetti","year":"2011","journal-title":"Am J Respir Crit Care Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1164\/rccm.201407-1277OC","article-title":"Early respiratory infection is associated with reduced spirometry in children with cystic fibrosis.","volume":"190","author":"Ramsey","year":"2014","journal-title":"Am J Respir Crit Care Med."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2021.111221","article-title":"Pseudomonas aeruginosa, the type of mutation, lung function, and nutritional status in adults with cystic fibrosis.","volume":"89","author":"John","year":"2021","journal-title":"Nutrition."},{"key":"B26","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1183\/09031936.00166412","article-title":"Factors associated with FEV1 decline in cystic fibrosis: analysis of the ECFS patient registry.","volume":"43","author":"Kerem","year":"2014","journal-title":"Eur Respir J."},{"key":"B27","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1093\/cid\/cir399","article-title":"Inflammatory responses to individual microorganisms in the lungs of children with cystic fibrosis.","volume":"53","author":"Gangell","year":"2011","journal-title":"Clin Infect Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.jcf.2020.12.015","article-title":"Changes in airway inflammation with Pseudomonas eradication in early cystic fibrosis.","volume":"20","author":"Garratt","year":"2021","journal-title":"J Cyst Fibros."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1056\/NEJMoa1301725","article-title":"Risk factors for bronchiectasis in children with cystic fibrosis.","volume":"368","author":"Sly","year":"2013","journal-title":"N Engl J Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.jpeds.2009.05.005","article-title":"Bronchiectasis in infants and preschool children diagnosed with cystic fibrosis after newborn screening.","volume":"155","author":"Stick","year":"2009","journal-title":"J Pediatr."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1186\/s40101-021-00269-7","article-title":"The determinants of survival among adults with cystic fibrosis-a cohort study.","volume":"40","author":"Durda-Masny","year":"2021","journal-title":"J Physiol Anthropol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1002\/ppul.23715","article-title":"Risk factors for mortality before age 18 years in cystic fibrosis.","volume":"52","author":"McColley","year":"2017","journal-title":"Pediatr Pulmonol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1183\/09031936.00043108","article-title":"Acquisition and eradication of P. aeruginosa in young children with cystic fibrosis.","volume":"33","author":"Douglas","year":"2009","journal-title":"Eur Respir J."},{"key":"B34","year":"2022","journal-title":"Cystic Fibrosis Foundation Patient Registry 2021 Annual Data Report."},{"key":"B35","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1002\/ppul.21397","article-title":"Age of Pseudomonas aeruginosa acquisition and subsequent severity of cystic fibrosis lung disease.","volume":"46","author":"Pittman","year":"2011","journal-title":"Pediatr Pulmonol."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz546","article-title":"Impact of Pseudomonas aeruginosa isolation on mortality and outcomes in an outpatient chronic obstructive pulmonary disease cohort.","volume":"7","author":"Jacobs","year":"2020","journal-title":"Open Forum Infect Dis."},{"key":"B37","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jinf.2013.09.003","article-title":"Infectious etiology of acute exacerbations in severe COPD patients.","volume":"67","author":"Domenech","year":"2013","journal-title":"J Infect."},{"key":"B38","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1159\/000490190","article-title":"Pseudomonas aeruginosa in chronic obstructive pulmonary disease patients with frequent hospitalized exacerbations: a prospective multicentre study.","volume":"96","author":"Rodrigo-Troyano","year":"2018","journal-title":"Respiration."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2466-14-103","article-title":"Pseudomonas aeruginosa isolates in severe chronic obstructive pulmonary disease: characterization and risk factors.","volume":"14","author":"Gallego","year":"2014","journal-title":"BMC Pulm Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.cmi.2020.04.007","article-title":"Pseudomonas aeruginosa and lung function decline in patients with bronchiectasis.","volume":"27","author":"Martinez-Garcia","year":"2021","journal-title":"Clin Microbiol Infect."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1007\/s10096-013-2044-0","article-title":"Bronchial microbiome of severe COPD patients colonised by Pseudomonas aeruginosa.","volume":"33","author":"Millares","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis."},{"key":"B42","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.rmed.2014.07.021","article-title":"Non cystic fibrosis bronchiectasis: a longitudinal retrospective observational cohort study of Pseudomonas persistence and resistance.","volume":"109","author":"McDonnell","year":"2015","journal-title":"Respir Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1164\/rccm.201309-1575OC","article-title":"The bronchiectasis severity index. An international derivation and validation study.","volume":"189","author":"Chalmers","year":"2014","journal-title":"Am J Respir Crit Care Med."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01953-2017","article-title":"The independent contribution of Pseudomonas aeruginosa infection to long-term clinical outcomes in bronchiectasis.","volume":"51","author":"Araujo","year":"2018","journal-title":"Eur Respir J."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1513\/AnnalsATS.201506-333OC","article-title":"A comprehensive analysis of the impact of Pseudomonas aeruginosa colonization on prognosis in adult bronchiectasis.","volume":"12","author":"Finch","year":"2015","journal-title":"Ann Am Thorac Soc."},{"key":"B46","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.cmi.2019.06.011","article-title":"Pseudomonas aeruginosa and risk of death and exacerbations in patients with chronic obstructive pulmonary disease: an observational cohort study of 22 053 patients.","volume":"26","author":"Eklof","year":"2020","journal-title":"Clin Microbiol Infect."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-014613","article-title":"Pseudomonas aeruginosa isolation in patients with non-cystic fibrosis bronchiectasis: a retrospective study.","volume":"8","author":"Wang","year":"2018","journal-title":"BMJ Open."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-021-01729-5","article-title":"Risk factors for Pseudomonas aeruginosa colonization in non-cystic fibrosis bronchiectasis and clinical implications.","volume":"22","author":"Kwok","year":"2021","journal-title":"Respir Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.rmed.2013.12.015","article-title":"Mortality in non-cystic fibrosis bronchiectasis: a prospective cohort analysis.","volume":"108","author":"Goeminne","year":"2014","journal-title":"Respir Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1111\/resp.12825","article-title":"Pseudomonas aeruginosa resistance patterns and clinical outcomes in hospitalized exacerbations of COPD.","volume":"21","author":"Rodrigo-Troyano","year":"2016","journal-title":"Respirology."},{"key":"B51","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/S0140-6736(10)61380-3","article-title":"Role of viral respiratory infections in asthma and asthma exacerbations.","volume":"376","author":"Busse","year":"2010","journal-title":"Lancet."},{"key":"B52","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.773600","article-title":"Viral induced effects on a vulnerable epithelium; lessons learned from paediatric asthma and eosinophilic oesophagitis.","volume":"12","author":"Watkinson","year":"2021","journal-title":"Front Immunol."},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-13-35","article-title":"Bacteria in sputum of stable severe asthma and increased airway wall thickness.","volume":"13","author":"Zhang","year":"2012","journal-title":"Respir Res."},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-018-0746-7","article-title":"Factors associated with bronchiectasis in patients with uncontrolled asthma; the NOPES score: a study in 398 patients.","volume":"19","author":"Padilla-Galo","year":"2018","journal-title":"Respir Res."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1111\/crj.12653","article-title":"Investigation of bronchiectasis in severe uncontrolled asthma.","volume":"12","author":"Dimakou","year":"2018","journal-title":"Clin Respir J."},{"key":"B56","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.","volume":"399","year":"2022","journal-title":"Lancet."},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3390\/children9091330","article-title":"Multidrug-resistant bacteria in children and adolescents with cystic fibrosis.","volume":"9","author":"Fainardi","year":"2022","journal-title":"Children."},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2018.e00795","article-title":"Antibiotic multidrug resistance in the cystic fibrosis airway microbiome is associated with decreased diversity.","volume":"4","author":"Hahn","year":"2018","journal-title":"Heliyon."},{"key":"B59","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2147\/COPD.S150250","article-title":"Antibiotic-resistant Pseudomonas aeruginosa infection in patients with bronchiectasis: prevalence, risk factors and prognostic implications.","volume":"13","author":"Gao","year":"2018","journal-title":"Int J Chron Obstruct Pulmon Dis."},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-017-2754-5","article-title":"Risk factors for multidrug-resistant pathogens in bronchiectasis exacerbations.","volume":"17","author":"Menendez","year":"2017","journal-title":"BMC Infect Dis."},{"key":"B61","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s15010-008-8125-9","article-title":"Mortality of COPD patients infected with multi-resistant Pseudomonas aeruginosa: a case and control study.","volume":"37","author":"Montero","year":"2009","journal-title":"Infection."},{"key":"B62","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/S2213-2600(20)30105-3","article-title":"Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.","volume":"8","year":"2020","journal-title":"Lancet Respir Med."},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-020-1291-8","article-title":"Trends in prevalence and incidence of chronic respiratory diseases from 1990 to 2017.","volume":"21","author":"Xie","year":"2020","journal-title":"Respir Res."},{"key":"B64","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1128\/IAI.00832-08","article-title":"Neutrophil recruitment to the lungs during bacterial pneumonia.","volume":"77","author":"Craig","year":"2009","journal-title":"Infect Immun."},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3390\/cells10092406","article-title":"Current understanding of the neutrophil transcriptome in health and disease.","volume":"10","author":"Garratt","year":"2021","journal-title":"Cells."},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21030851","article-title":"Neutrophil adaptations upon recruitment to the lung: new concepts and implications for homeostasis and disease.","volume":"21","author":"Giacalone","year":"2020","journal-title":"Int J Mol Sci."},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1186\/s40348-016-0066-2","article-title":"Neutrophil plasticity enables the development of pathological microenvironments: implications for cystic fibrosis airway disease.","volume":"3","author":"Margaroli","year":"2016","journal-title":"Mol Cell Pediatr."},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01771-2018","article-title":"The cumulative effect of inflammation and infection on structural lung disease in early cystic fibrosis.","volume":"54","author":"Rosenow","year":"2019","journal-title":"Eur Respir J."},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01910-2017","article-title":"Elastase activity on sputum neutrophils correlates with severity of lung disease in cystic fibrosis.","volume":"51","author":"Dittrich","year":"2018","journal-title":"Eur Respir J."},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00769-2020","article-title":"Sputum neutrophil elastase associates with microbiota and Pseudomonas aeruginosa in bronchiectasis.","volume":"56","author":"Oriano","year":"2020","journal-title":"Eur Respir J."},{"key":"B71","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/JLB.5HI1117-454RR","article-title":"Frontline Science: pathological conditioning of human neutrophils recruited to the airway milieu in cystic fibrosis.","volume":"104","author":"Forrest","year":"2018","journal-title":"J Leukoc Biol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1164\/rccm.201803-0442OC","article-title":"Elastase exocytosis by airway neutrophils is associated with early lung damage in children with cystic fibrosis.","volume":"199","author":"Margaroli","year":"2019","journal-title":"Am J Respir Crit Care Med."},{"key":"B73","doi-asserted-by":"publisher","first-page":"4335","DOI":"10.1073\/pnas.0712386105","article-title":"Profound functional and signaling changes in viable inflammatory neutrophils homing to cystic fibrosis airways.","volume":"105","author":"Tirouvanziam","year":"2008","journal-title":"Proc Natl Acad Sci USA."},{"key":"B74","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/imcb.12547","article-title":"Pseudomonas aeruginosa modulates neutrophil granule exocytosis in an in vitro model of airway infection.","volume":"100","author":"Laucirica","year":"2022","journal-title":"Immunol Cell Biol."},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-019-1145-4","article-title":"Neutrophil elastase as a biomarker for bacterial infection in COPD.","volume":"20","author":"Thulborn","year":"2019","journal-title":"Respir Res."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1164\/rccm.201605-1027OC","article-title":"Neutrophil elastase activity is associated with exacerbations and lung function decline in bronchiectasis.","volume":"195","author":"Chalmers","year":"2017","journal-title":"Am J Respir Crit Care Med."},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.581","article-title":"Sputum neutrophil elastase and its relation to pediatric bronchiectasis severity: a cross-sectional study.","volume":"5","author":"Ali","year":"2022","journal-title":"Health Sci Rep."},{"key":"B78","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.it.2017.07.003","article-title":"Neutrophilic inflammation in asthma and association with disease severity.","volume":"38","author":"Ray","year":"2017","journal-title":"Trends Immunol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/s0091-6749(95)70128-1","article-title":"Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation.","volume":"95","author":"Fahy","year":"1995","journal-title":"J Allergy Clin Immunol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1164\/ajrccm.157.2.9703070","article-title":"Increased levels of elastase and alpha1-antitrypsin in sputum of asthmatic patients.","volume":"157","author":"Vignola","year":"1998","journal-title":"Am J Respir Crit Care Med."},{"key":"B81","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1183\/09031936.02.00226302","article-title":"Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma.","volume":"19","author":"Wark","year":"2002","journal-title":"Eur Respir J."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1164\/ajrccm.160.5.9806170","article-title":"Neutrophilic inflammation in severe persistent asthma.","volume":"160","author":"Jatakanon","year":"1999","journal-title":"Am J Respir Crit Care Med."},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-14-8","article-title":"Inhibition of neutrophil elastase attenuates airway hyperresponsiveness and inflammation in a mouse model of secondary allergen challenge: neutrophil elastase inhibition attenuates allergic airway responses.","volume":"14","author":"Koga","year":"2013","journal-title":"Respir Res."},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2020.104101","article-title":"Early recruited neutrophils promote asthmatic inflammation exacerbation by release of neutrophil elastase.","volume":"352","author":"Weng","year":"2020","journal-title":"Cell Immunol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/0034-5687(94)00123-h","article-title":"Neutrophil elastase inhibitor reduces asthmatic responses in allergic sheep.","volume":"100","author":"Fujimoto","year":"1995","journal-title":"Respir Physiol."},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100239","article-title":"Transcriptional firing represses bactericidal activity in cystic fibrosis airway neutrophils.","volume":"2","author":"Margaroli","year":"2021","journal-title":"Cell Rep Med."},{"key":"B87","doi-asserted-by":"publisher","first-page":"437","DOI":"10.4103\/0970-2113.164159","article-title":"Assessment of phagocytic activity of neutrophils in chronic obstructive pulmonary disease.","volume":"32","author":"Shanmugam","year":"2015","journal-title":"Lung India."},{"key":"B88","first-page":"387","article-title":"Reduced phagocytosis of pathogenic bacteria by neutrophils from COPD patients.","volume":"40","author":"Thomas","year":"2012","journal-title":"Eur Respir J."},{"key":"B89","first-page":"738","article-title":"Neutrophil phagocytic activity in AECOPD.","volume":"38","author":"Lavinskiene","year":"2011","journal-title":"Eur Respir J."},{"key":"B90","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1164\/rccm.201712-2423OC","article-title":"Blood neutrophils are reprogrammed in bronchiectasis.","volume":"198","author":"Bedi","year":"2018","journal-title":"Am J Respir Crit Care Med."},{"key":"B91","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.3390\/biom11081065","article-title":"Impaired neutrophil phagocytosis and receptor expression in non-CF bronchiectasis.","volume":"42","author":"Chalmers","year":"2013","journal-title":"Eur Respir J."},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1186\/2045-7022-3-28","article-title":"Inhaled corticosteroid treatment for 6 months was not sufficient to normalize phagocytosis in asthmatic children.","volume":"3","author":"da Silva-Martins","year":"2013","journal-title":"Clin Transl Allergy."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria.","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science."},{"key":"B94","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1083\/jcb.200606027","article-title":"Novel cell death program leads to neutrophil extracellular traps.","volume":"176","author":"Fuchs","year":"2007","journal-title":"J Cell Biol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1038\/cdd.2009.96","article-title":"Viable neutrophils release mitochondrial DNA to form neutrophil extracellular traps.","volume":"16","author":"Yousefi","year":"2009","journal-title":"Cell Death Differ."},{"key":"B96","doi-asserted-by":"publisher","first-page":"7413","DOI":"10.4049\/jimmunol.1000675","article-title":"A novel mechanism of rapid nuclear neutrophil extracellular trap formation in response to Staphylococcus aureus.","volume":"185","author":"Pilsczek","year":"2010","journal-title":"J Immunol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1038\/nm.2847","article-title":"Infection-induced NETosis is a dynamic process involving neutrophil multitasking in vivo.","volume":"18","author":"Yipp","year":"2012","journal-title":"Nat Med."},{"key":"B98","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.4049\/jimmunol.1201719","article-title":"Neutrophil extracellular traps: double-edged swords of innate immunity.","volume":"189","author":"Kaplan","year":"2012","journal-title":"J Immunol."},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00081","article-title":"Neutrophil extracellular traps and its implications in inflammation: an overview.","volume":"8","author":"Delgado-Rizo","year":"2017","journal-title":"Front Immunol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jcf.2011.09.008","article-title":"Ultrastructural characterization of cystic fibrosis sputum using atomic force and scanning electron microscopy.","volume":"11","author":"Manzenreiter","year":"2012","journal-title":"J Cyst Fibros."},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-015-0221-7","article-title":"Neutrophil extracellular trap (NET) formation characterises stable and exacerbated COPD and correlates with airflow limitation.","volume":"16","author":"Grabcanovic-Musija","year":"2015","journal-title":"Respir Res."},{"key":"B102","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/S2213-2600(20)30504-X","article-title":"Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort study.","volume":"9","author":"Keir","year":"2021","journal-title":"Lancet Respir Med."},{"key":"B103","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1165\/rcmb.2020-0168OC","article-title":"Neutrophil extracellular traps increase airway mucus viscoelasticity and slow mucus particle transit.","volume":"64","author":"Linssen","year":"2021","journal-title":"Am J Respir Cell Mol Biol."},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/408935","article-title":"Free DNA in cystic fibrosis airway fluids correlates with airflow obstruction.","volume":"2015","author":"Marcos","year":"2015","journal-title":"Mediators Inflamm."},{"key":"B105","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1136\/thoraxjnl-2017-210134","article-title":"Delayed neutrophil apoptosis enhances NET formation in cystic fibrosis.","volume":"73","author":"Gray","year":"2018","journal-title":"Thorax."},{"key":"B106","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jaci.2017.04.022","article-title":"Neutrophil extracellular traps are associated with disease severity and microbiota diversity in patients with chronic obstructive pulmonary disease.","volume":"141","author":"Dicker","year":"2018","journal-title":"J Allergy Clin Immunol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1164\/rccm.201810-1869OC","article-title":"Extracellular DNA, neutrophil extracellular traps, and inflammasome activation in severe asthma.","volume":"199","author":"Lachowicz-Scroggins","year":"2019","journal-title":"Am J Respir Crit Care Med."},{"key":"B108","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jcf.2013.12.009","article-title":"A randomized double blind, placebo controlled phase 2 trial of BIIL 284 BS (an LTB4 receptor antagonist) for the treatment of lung disease in children and adults with cystic fibrosis.","volume":"13","author":"Konstan","year":"2014","journal-title":"J Cyst Fibros."},{"key":"B109","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jcf.2013.10.007","article-title":"BIIL 284 reduces neutrophil numbers but increases P. aeruginosa bacteremia and inflammation in mouse lungs.","volume":"13","author":"Doring","year":"2014","journal-title":"J Cyst Fibros."},{"key":"B110","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.resmic.2018.05.001","article-title":"Phage therapy against Achromobacter xylosoxidans lung infection in a patient with cystic fibrosis: a case report.","volume":"169","author":"Hoyle","year":"2018","journal-title":"Res Microbiol."},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.3390\/v13010060","article-title":"A case of phage therapy against pandrug-resistant Achromobacter xylosoxidans in a 12-year-old lung-transplanted cystic fibrosis patient.","volume":"13","author":"Lebeaux","year":"2021","journal-title":"Viruses."},{"key":"B112","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1164\/rccm.201904-0839LE","article-title":"Bacteriophage therapy of ventilator-associated pneumonia and empyema caused by Pseudomonas aeruginosa.","volume":"200","author":"Maddocks","year":"2019","journal-title":"Am J Respir Crit Care Med."},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac453","article-title":"Phage therapy of Mycobacterium infections: compassionate-use of phages in twenty patients with drug-resistant Mycobacterial disease.","author":"Dedrick","year":"2022","journal-title":"Clin Infect Dis."},{"key":"B114","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1016\/j.cell.2022.04.024","article-title":"Host and pathogen response to bacteriophage engineered against Mycobacterium abscessus lung infection.","volume":"185","author":"Nick","year":"2022","journal-title":"Cell."},{"key":"B115","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41564-019-0634-z","article-title":"Safety of bacteriophage therapy in severe Staphylococcus aureus infection.","volume":"5","author":"Petrovic Fabijan","year":"2020","journal-title":"Nat Microbiol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1128\/AAC.01426-15","article-title":"Antipseudomonal bacteriophage reduces infective burden and inflammatory response in murine lung.","volume":"60","author":"Pabary","year":"2016","journal-title":"Antimicrob Agents Chemother."},{"key":"B117","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1086\/651135","article-title":"Bacteriophages can treat and prevent Pseudomonas aeruginosa lung infections.","volume":"201","author":"Debarbieux","year":"2010","journal-title":"J Infect Dis."},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00379-19","article-title":"Phage therapy of pneumonia is not associated with an overstimulation of the inflammatory response compared to antibiotic treatment in mice.","volume":"63","author":"Dufour","year":"2019","journal-title":"Antimicrob Agents Chemother."},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-37636-x","article-title":"Phage therapy against Pseudomonas aeruginosa infections in a cystic fibrosis zebrafish model.","volume":"9","author":"Cafora","year":"2019","journal-title":"Sci Rep."},{"key":"B120","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/s41423-020-0412-0","article-title":"Neutrophil chemoattractant receptors in health and disease: double-edged swords.","volume":"17","author":"Metzemaekers","year":"2020","journal-title":"Cell Mol Immunol."},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2017.00217","article-title":"Multiple phenotypic changes define neutrophil priming.","volume":"7","author":"Miralda","year":"2017","journal-title":"Front Cell Infect Microbiol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1165\/rcmb.2013-0114OC","article-title":"Roles of lung epithelium in neutrophil recruitment during pneumococcal pneumonia.","volume":"50","author":"Yamamoto","year":"2014","journal-title":"Am J Respir Cell Mol Biol."},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01438","article-title":"Role of cystic fibrosis bronchial epithelium in neutrophil chemotaxis.","volume":"11","author":"Cabrini","year":"2020","journal-title":"Front Immunol."},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01330","article-title":"Use of a primary epithelial cell screening tool to investigate phage therapy in cystic fibrosis.","volume":"9","author":"Trend","year":"2018","journal-title":"Front Pharmacol."},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-08336-9","article-title":"Pro- and anti-inflammatory responses of peripheral blood mononuclear cells induced by Staphylococcus aureus and Pseudomonas aeruginosa phages.","volume":"7","author":"Van Belleghem","year":"2017","journal-title":"Sci Rep."},{"key":"B126","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s00430-006-0011-4","article-title":"Effects of bacteriophages on free radical production and phagocytic functions.","volume":"195","author":"Przerwa","year":"2006","journal-title":"Med Microbiol Immunol."},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.01112","article-title":"T4 phage tail adhesin Gp12 counteracts LPS-induced inflammation in vivo.","volume":"7","author":"Miernikiewicz","year":"2016","journal-title":"Front Microbiol."},{"key":"B128","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4049\/jimmunol.15.1.43","article-title":"The effect of bacteriophage upon the phenomena of leukocytosis and phagocytosis.","volume":"15","author":"Nelson","year":"1928","journal-title":"J Immunol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3390\/pharmaceutics14091916","article-title":"Bacteriophage and phagocytosis, i. effect on resistant and dead bacteria.","volume":"15","author":"Smith","year":"1928","journal-title":"J Immunol."},{"key":"B130","doi-asserted-by":"crossref","DOI":"10.5962\/bhl.title.31194","author":"d\u2019Herelle","year":"1922","journal-title":"The Bacteriophage, its Role in Immunity."},{"key":"B131","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1007\/s12275-011-1512-4","article-title":"Antibacterial efficacy of lytic Pseudomonas bacteriophage in normal and neutropenic mice models.","volume":"49","author":"Tiwari","year":"2011","journal-title":"J Microbiol."},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0153777","article-title":"Encapsulation of bacteriophage in liposome accentuates its entry in to macrophage and shields it from neutralizing antibodies.","volume":"11","author":"Singla","year":"2016","journal-title":"PLoS One."},{"key":"B133","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1086\/343812","article-title":"Killing of Mycobacterium avium and Mycobacterium tuberculosis by a mycobacteriophage delivered by a nonvirulent mycobacterium: a model for phage therapy of intracellular bacterial pathogens.","volume":"186","author":"Broxmeyer","year":"2002","journal-title":"J Infect Dis."},{"key":"B134","doi-asserted-by":"publisher","first-page":"4653","DOI":"10.1007\/s00253-014-5643-5","article-title":"Bacteriophage-aided intracellular killing of engulfed methicillin-resistant Staphylococcus aureus (MRSA) by murine macrophages.","volume":"98","author":"Kaur","year":"2014","journal-title":"Appl Microbiol Biotechnol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1128\/AAC.01513-06","article-title":"Experimental phage therapy against Staphylococcus aureus in mice.","volume":"51","author":"Capparelli","year":"2007","journal-title":"Antimicrob Agents Chemother."},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/482863","article-title":"The effect of bacteriophage preparations on intracellular killing of bacteria by phagocytes.","volume":"2015","author":"Jonczyk-Matysiak","year":"2015","journal-title":"J Immunol Res."},{"key":"B137","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1089\/vim.2012.0071","article-title":"Influence of bacteriophage preparations on intracellular killing of bacteria by human phagocytes in vitro.","volume":"26","author":"Kurzepa-Skaradzinska","year":"2013","journal-title":"Viral Immunol."},{"key":"B138","doi-asserted-by":"publisher","first-page":"2942","DOI":"10.4049\/jimmunol.174.5.2942","article-title":"Human TLR10 is a functional receptor, expressed by B cells and plasmacytoid dendritic cells, which activates gene transcription through MyD88.","volume":"174","author":"Hasan","year":"2005","journal-title":"J Immunol."},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00461","article-title":"Toll-like receptor signaling pathways.","volume":"5","author":"Kawasaki","year":"2014","journal-title":"Front Immunol."},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1111\/cmi.12941","article-title":"Staphylococcal superantigen-like protein 13 activates neutrophils via formyl peptide receptor 2.","volume":"20","author":"Zhao","year":"2018","journal-title":"Cell Microbiol."},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00595","article-title":"Progress in model systems of cystic fibrosis mucosal inflammation to understand aberrant neutrophil activity.","volume":"11","author":"Laucirica","year":"2020","journal-title":"Front Immunol."},{"key":"B142","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1159\/000502489","article-title":"Animal models reflecting chronic obstructive pulmonary disease and related respiratory disorders: translating pre-clinical data into clinical relevance.","volume":"12","author":"Tanner","year":"2020","journal-title":"J Innate Immun."},{"key":"B143","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.vetimm.2016.01.008","article-title":"Tissue-specific mRNA expression profiles of porcine Toll-like receptors at different ages in germ-free and conventional pigs.","volume":"171","author":"Shao","year":"2016","journal-title":"Vet Immunol Immunopathol."},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17952-4","article-title":"Conditionally reprogrammed primary airway epithelial cells maintain morphology, lineage and disease specific functional characteristics.","volume":"7","author":"Martinovich","year":"2017","journal-title":"Sci Rep."},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1002\/anbr.202000111","article-title":"Air-liquid interface cultures of the healthy and diseased human respiratory tract: promises, challenges and future directions.","volume":"1","author":"Baldassi","year":"2021","journal-title":"Adv Nanobiomed Res."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.1069929\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T13:57:59Z","timestamp":1679061479000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.1069929\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,14]]},"references-count":145,"alternative-id":["10.3389\/fmed.2022.1069929"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.1069929","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,14]]},"article-number":"1069929"}}